Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix

ClinicalTrials.gov ID: NCT00054067

Public ClinicalTrials.gov record NCT00054067. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 6:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Treatment of Patients With Stage IB2 Carcinoma of the Cervix: A Randomized Comparison of Radical Hysterectomy and Tailored Chemo-Radiation Versus Primary Chemo-Radiation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which regimen of radiation therapy combined with chemotherapy, with or without surgery, is more effective in treating early cancer of the cervix. PURPOSE: Randomized phase III trial to compare the effectiveness of surgery followed by different regimens of radiation therapy and chemotherapy with that of chemotherapy and radiation therapy alone in treating patients who have stage I cancer of the cervix.

Study identification

NCT ID
NCT00054067
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gynecologic Oncology Group
Network
Enrollment
Not listed

Conditions and interventions

Interventions

Drug · Procedure · Radiation

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2003 (Type not available)
Primary completion
Apr 2005 (Actual)
Completion
Not listed
Last update posted
Apr 11, 2013

Started 2003

United States locations

U.S. sites
49
U.S. states
25
U.S. cities
46
Facility City State ZIP Site status
University of Alabama at Birmingham Comprehensive Cancer Center Birmingham Alabama 35294-3300 —
CCOP - Western Regional, Arizona Phoenix Arizona 85006-2726 —
Jonsson Comprehensive Cancer Center, UCLA Los Angeles California 90095-1740 —
Women's Cancer Center at Community Hospital of Los Gatos Los Gatos California 95032 —
Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center Orange California 92868 —
Yale Comprehensive Cancer Center New Haven Connecticut 06520-8028 —
CCOP - Christiana Care Health Services Newark Delaware 19713 —
Walter Reed Army Medical Center Washington D.C. District of Columbia 20307-5001 —
Rush-Presbyterian-St. Luke's Medical Center Chicago Illinois 60612-3824 —
MBCCOP - University of Illinois at Chicago Chicago Illinois 60612 —
University of Chicago Cancer Research Center Chicago Illinois 60637-1470 —
CCOP - Central Illinois Decatur Illinois 62794-9640 —
CCOP - Evanston Evanston Illinois 60201 —
CCOP - Carle Cancer Center Urbana Illinois 61801 —
Indiana University Cancer Center Indianapolis Indiana 46202-5289 —
Saint Joseph Regional Medical Center South Bend Indiana 46617 —
Holden Comprehensive Cancer Center at University of Iowa Iowa City Iowa 52242-1002 —
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda Maryland 20892-1182 —
CCOP - Michigan Cancer Research Consortium Ann Arbor Michigan 48106 —
CCOP - Grand Rapids Grand Rapids Michigan 49503 —
CCOP - Kalamazoo Kalamazoo Michigan 49007-3731 —
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416 —
University of Mississippi Medical Center Jackson Mississippi 39216-4505 —
Ellis Fischel Cancer Center at University of Missouri - Columbia Columbia Missouri 65203 —
CCOP - Kansas City Kansas City Missouri 64131 —
CCOP - Cancer Research for the Ozarks Springfield Missouri 65807 —
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68106 —
Cooper University Hospital Camden New Jersey 08103-1489 —
Memorial Sloan-Kettering Cancer Center New York New York 10021 —
Long Island Cancer Center at Stony Brook University Hospital Stony Brook New York 11790-7775 —
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill North Carolina 27599-7295 —
Duke Comprehensive Cancer Center Durham North Carolina 27710 —
Charles M. Barrett Cancer Center at University Hospital Cincinnati Ohio 45267-0526 —
Ireland Cancer Center Cleveland Ohio 44106 —
Arthur G. James Cancer Hospital - Ohio State University Columbus Ohio 43210-1240 —
CCOP - Columbia River Oncology Program Portland Oregon 97225 —
Abington Memorial Hospital Abington Pennsylvania 19001-3788 —
CCOP - Geisinger Clinic and Medical Center Danville Pennsylvania 17822-2001 —
Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey Pennsylvania 17033-0850 —
Abramson Cancer Center at University of Pennsylvania Medical Center Philadelphia Pennsylvania 19104-4283 —
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia Philadelphia Pennsylvania 19107 —
Magee-Womens Hospital Pittsburgh Pennsylvania 15213-3180 —
Southeast Gynecologic Oncology Associates Knoxville Tennessee 37917 —
Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center Nashville Tennessee 37232-2516 —
University of Texas Medical Branch Galveston Texas 77555-0587 —
University of Texas - MD Anderson Cancer Center Houston Texas 77030-4009 —
CCOP - Scott and White Hospital Temple Texas 76508 —
Fletcher Allen Health Care - Medical Center Campus Burlington Vermont 05401 —
University of Wisconsin Comprehensive Cancer Center Madison Wisconsin 53792-6188 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00054067, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 11, 2013 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00054067 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →